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carbapenem resistance (i.e. case 2). The occurrence of these resis-
tance mechanisms in immunocompromised cancer patients who
have extensive healthcare and antibiotic exposure as well as hospital
admission episodes increases the risk of infection spread in health-
care settings aswell as in community (case 1). The second case shows
that this resistance phenomenon can be found even in children.
These cases are, to the best of our knowledge, the first reports of such
infections from eastern India. Because of the proximity of this region
to highly populous areas and to international trade, tourism, and
travel, the likelihood of international dissemination may be high.
Surveillance of mcr-mediated colistin resistance may reveal more
cases and facilitate better infection control.
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To the Editor—Brucellosis, or Mediterranean fever, is an impor-
tant zoonotic disease caused by various species of the gram-
negative bacteria Brucella. The well-known species of Brucella
are B. abortus, B. melitensis, B. ovis, B. canis, and B. suis, which
infect cows, goats, sheep, dogs, and pigs, respectively.1 This infec-
tious disease can be transmitted from infected animals to humans
through direct contact, tissues (placenta or aborted tissues), or
animal products (dairy products). Human to human transmission
is rare.2 Brucellosis imposes considerable economic losses in many
countries each year via damage to livestock through reduced
fertility, abortion, and decline in milk production and via humans
through significant loss of work days of infected persons and
their families and long-term treatment costs.3 According to the
World Health Organization, >500,000 new cases of brucellosis
are reported annually worldwide; however, undetected cases are
estimated to be 4× this number.4,5 The incidence rate of this infec-
tion varies from <0.01 to >200 cases per 100,000 population in
different parts of the world, depending on geographical area,
hygiene level, eating habits, occupation, and other factors.6
Notably, the incidence rate of this disease (per 100,000 population)
is very low in many countries: the United States (0.04), Italy (0.9),
Spain (1.3), Russia (0.4), Chile (0.006) France (0.05), South Korea
(0.1), and China (0.4). It has even been eradicated in some coun-
tries: Sweden, Denmark, Finland, Germany, the United Kingdom
(excluding Northern Ireland), Austria, Netherlands, Belgium,
Luxembourg, Norway, and Switzerland. Unfortunately, the infec-
tion is still endemic inMiddle East countries, where high incidence
rates (per 100,000 population) prevail: Iran (23.8), Turkey (26.2),
Syria (160.3), Saudi Arabia (21.4), and Iraq (27.8).7 In Iran,
~16,000 cases of brucellosis are reported annually.8,9 According
to data from the National Commission on Communicable
Diseases Control, in 1989, the annual incidence exceeded 100 cases
per 100,000 population, but in 2013, the annual incidence had
fallen to 23.8 cases per 100,000 population. Despite this decline,
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human brucellosis remains an important health issue in Iran.7
Distribution of the disease is uneven across the country, and
although cases of the disease have been reported in all provinces
of the country, the incidence is higher in the western and
northwestern provinces, in the Zagros Mountain region.10 In an
analytical study in 2011, Pakzad et al10 reported the highest inci-
dence rate of brucellosis in Coohrang County of Chaharmahal-
Bakhtiari province, with 317 cases per 100,000 population. In
subsequent years, Charuymaq County of East Azerbaijan province
had rates of 384 cases per 100,000 population in 2012, 534 in 2013,
and 583 in 2014, which was at most 14575 and 25 times higher than
the average incidence rate of brucellosis in the USA and Iran,
respectively.10 In 2012, Almasi et al11 also reported that the inci-
dence rate of brucellosis in Kermanshah is ~275 per 100,000 cases,
and in 2009, Bokaie et al12 reported that the incidence rate in
Western Azerbaijan was ~175 per 100,000. In Hamadan, the inci-
dence rate has been reported to be 130 per 100,000 cases. In prov-
inces outside the Zagros Mountains, such as Qom and Tehran, the
incidences rate were 7 and 10 per 100,000 cases, respectively.9
Overall, the incidence rate of brucellosis in the Zagros Mountains
is significantly higher than other provinces. This region may be
also related to high incidence rates of brucellosis in Iran, Iraq,
and Turkey. Thus, we investigated the factors that affect the rate
of brucellosis in the Zagros Mountains to recommend ways to
reduce the prevalence of this disease.
The Zagros Mountains, with a total length of 1,600 km, spread
across Iran, Iraq, and Turkey. They begin in northwestern of
Iran, continue along i western borders, and end at the strait of
Hormuz. They encompass the provinces of West Azerbaijan,
Lorestan, Hamadan, Markazi, Isfahan, Fars, Kurdistan,
Kermanshah, Ilam, Kohgiluyeh and Boyerahmad, Chaharmahal
and Bakhtiari, Khuzestan and Kerman, Bushehr and Hormozgan.13
The earliest agriculture and animal husbandry began here thou-
sands of years ago in Susa and Anshan, the ancient cities located
in these mountains.14 The people of the Zagros Mountains have
been sheep and goat (boazer goat) herders since ~10,000 B.C.E.
The Zagros people have always been in contact with animals
and livestock through hunting and migratory or rural life; there-
fore, they have continually been at risk for zoonotic diseases.15
The high incidence of brucellosis in this area has many
causes.5,16–19 Several studies have reported a higher density of live-
stock in these areas. The Zagros region has ~43% of the total pop-
ulation (>34 million people) of Iran, and it is home to 52% of all
livestock in the country, including cattle, sheep, and goats. Most of
the country’s nomadic and rural population resides in the Zagros
Mountains, with close and continual contact with animals. These
residents often assist in animal deliveries and come into contact
with placenta and related discharges, which are the most potential
agents for transmission of Brucella bacteria. These nomadic areas
have a low level of hygiene and lack of access to antibacterial deter-
gents and disinfectants. The population in these rural areas, espe-
cially nomads, lack sufficient education regarding transmission,
manifestation, and complications of brucellosis. They have high
and continuous consumption of nonpasteurized dairy products,
and they consume raw and semi-raw dairy products (eg, milk
and cream). Due to continued movement and living in areas with
difficult accessibility, monitoring and vaccination of nomad herds
is very difficult and not very effective. Often, several nomads come
together in one place, causing cross transmission of Brucella from
one herd to another. Transmission also occurs from livestock to
wild animals living in the Zagros Mountains, which makes them
reservoirs of infection. Other reasons for the high brucellosis rate
include unauthorized animal trafficking from neighboring coun-
tries and lack of a quarantine system at the borders; lack of appro-
priate identification system for infectious disease in livestock;
traditional, unauthorized, and unsanitary slaughter of animals;
and lack of funds.
Despite all these obstacles, we believe that reducing or even
eradicating this infection in the Zagros region and more generally
in Iran in the long term is possible. We need more effective plans,
efforts, cooperation, and especially aid from international organi-
zations such as WHO. Education is a low-cost but very effective
measure that increases awareness of and information about
brucellosis, its transmission, complications, manifestations, and
risk factors. Personal hygiene when assisting animal delivery,
boiling milk, and disuse of raw dairy products are other areas of
education that can be relatively easily accomplished. Allocating
free or cheap drug and health supplies to aid with hygiene can help
reduce this infection in nomadic and rural areas. Monitoring and
conducting regular vaccination of livestock, preventing animal
trafficking, and creating a quarantine system at the borders to iden-
tify sick animals are other examples of appropriate measures that
will contribute to achieving this valuable goal.4
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To the Editor—Antibiotic overuse is a persistent public health
problem that has contributed to an alarming increase in the preva-
lence of antibiotic resistance.1 In the United States, >70% of antibi-
otic courses are prescribed in ambulatory settings.2 To encourage the
appropriate use of antibiotics in outpatient practices, the Centers for
Disease Control and Prevention (CDC) released the Core Elements
of Outpatient Antibiotic Stewardship (hereafter Core Elements).3
However, detailed evaluations of how practices implement and sus-
tain the Core Elements are lacking.
From January through June 2019, an antimicrobial stewardship
quality improvement initiative was conducted by the American
Academy of Pediatrics Chapter Quality Network (AAP-CQN),
Colorado Department of Public Health and Environment, and
the CDC. In this project, 8 outpatient pediatric practices in
Colorado were enrolled: 3 practices that were part of larger systems
and 5 independent practices. All practices but 1 were urban or sub-
urban. The initiative utilized the Core Elements and Model for
Improvement frameworks.3 Practices implemented interventions
to improve prescribing for pharyngitis and acute otitis media.
The AAP-CQN provided webinars, learning sessions, monthly
tracking and reporting, and Maintenance of Certification
(MOC) credit. The ability of the practices to continue antibiotic
stewardship following the conclusion of the initiative was assessed.
Using surveys and telephone-based semistructured interviews
with physician champions, we assessed the ability of practices to
sustain the Core Elements of commitment, tracking and reporting,
and education and expertise. Because the initial intervention
focused on evaluation of the Core Element “action for policy
and practice,” our interviews targeted the other Core Elements.
The project was determined exempt by the AAP Institutional
Review Board.
Most practices identified a leader for antibiotic stewardship (7 of 8)
and intended to display commitment posters (5 of 7).4 Most had
access to antibiotic expertise (6 of 8) and planned to provide ongoing
education regarding antibiotic use (6 of 8). Few practices had
established systems for ongoing antibiotic stewardship-related duties
(4 of 8), tracking (5 of 8), or reporting (3 of 7).
Interviews identified 6 barriers to sustaining the 3 Core
Elements (Table 1). Lack of control and competing priorities
complicated practices’ capacity to display commitment. Of the
5 practices reporting implementation of a commitment poster
on the survey, only 2 affirmed the finding during interviews.
Barriers to displaying posters included modifying the CDC
template, inserting provider photos, and printing logistics. For prac-
tices that were part of a larger healthcare system, the need to obtain
administrative approval (for information technology (IT) support or
to hang commitment posters) was a key limitation.
Barriers to tracking and reporting included time constraints
and lack of information technology (IT) support. Only 2 practices
had IT support. Practices reported that manual or electronic
abstraction took substantial time (range, 4–20 hours by a physician
or clinic manager). Consequently, 5 practices did not plan to con-
tinue tracking and reporting, and 3 practices planned abbreviated
and less frequent (every 3–6 months) tracking and reporting.
Practices were most likely to sustain tracking and reporting if a
nonphysician was responsible for data.
Barriers to sustaining education/expertise included scheduling
and lack of resources (eg, regional experts). In the absence of MOC
and outside support, the structures of most practices did not
support scheduled education on antibiotic stewardship.
To sustain antibiotic stewardship, practices would benefit from
increased availability of practical strategies and tools. Strategies to
support the commitment to the Core Elements might include a
centralized online system for practices to design and order custom
commitment posters. For our initiative, AAP-Colorado created and
supplied posters, which were well received. Because tracking and
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